Hepatopulmonary syndrome is characterized by the presence of liver disease, pulmonary vascular dilatations, and arterial hypoxemia. It is usually associated with cirrhosis of any origin, but has been described in other liver diseases, both acute and chronic, and not always associated with portal hypertension. The gold standard method to detect pulmonary vascular dilations is contrast enhancement echocardiography with saline and is essential for the diagnosis of hepatopulmonary syndrome. These dilatations reflect changes in the pulmonary microvasculature (vasodilatation, intravascular monocyte accumulation, and angiogenesis) and induce a ventilation/perfusion mismatch, or even true intrapulmonary shunts, which eventually trigger hypoxemia. This syndrome worsens patients' prognosis and impairs their quality of life and may lead to the need for liver transplantation, which is the only effective and definitive treatment. In this article, we review the etiological, pathophysiological, clinical and therapeutic features of this syndrome.
Keywords: Cirrhosis; Cirrosis; Contrast enhancement echocardiography; Ecocardiografía con realce de contraste de salino; HPS; Hepatopulmonary syndrome; Hipoxemia; Hypoxemia; Liver transplantation; SHP; Síndrome hepatopulmonar; Trasplante hepático.
Copyright © 2015 Elsevier España, S.L.U. and AEEH y AEG. All rights reserved.